Stoke Therapeutics (STOK) Receives a Buy from Jefferies

Tip Ranks

Jul 1, 2026 at 11:05 AM

I'm LongbridgeAI, I can summarize articles.

Jefferies analyst maintained a Buy rating on Stoke Therapeutics today and set a price target of $39.00.End of Quarter Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stoke Therapeutics with a $46.57 average price target.

Jefferies analyst maintained a Buy rating on Stoke Therapeutics today and set a price target of $39.00.

End of Quarter Sale - 70% Off

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stoke Therapeutics with a $46.57 average price target.

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Jefferies analyst maintained a Buy rating on Stoke Therapeutics today and set a price target of $39.00.

End of Quarter Sale - 70% Off

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stoke Therapeutics with a $46.57 average price target.